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Introduction {#sec1}
============

Stem cells play important roles in tissue homeostasis and development. In adult organisms, they ensure continuous replacement of dying or damaged cells, while during development they generate most of the cell types in a developing organ. To fulfill this task, stem cells can maintain an undifferentiated state, but at the same time generate daughter cells that are lineage-restricted and ultimately undergo terminal differentiation. Understanding how the balance between self-renewal and differentiation is controlled within a stem cell lineage is important since defects in the control of this process can result in tissue degeneration or tumorigenesis.

*Drosophila* neuroblasts (Nbs) are one of the best-understood model systems for stem cell biology ([@bib22; @bib43]). In a series of asymmetric cell divisions (ACDs) that occur during embryonic, larval, and pupal stages of fly development, Nbs give rise to all neurons and glia cells in the adult *Drosophila* brain. Based on their lineage, two types of Nbs can be distinguished ([@bib5; @bib10; @bib12]). Type I Nbs divide asymmetrically into a large cell that retains Nb characteristics and a smaller, so-called ganglion mother cell (GMC) that undergoes just one more terminal division to create two differentiating neurons. Type II Nbs also divide asymmetrically, but in this case, the smaller daughter cell continues to divide asymmetrically. It initiates expression of the transcription factor Asense ([@bib12]) to become an intermediate neural progenitor (INP) that divides asymmetrically into one INP and one GMC, which in turn gives rise to two neurons. In both type I and type II Nbs and in the INPs, the difference between the two daughter cells is established via the asymmetric segregation of the cell-fate determinants Numb, Prospero (Pros), and Brat. In mitosis, these proteins concentrate in a cortical crescent and are inherited exclusively by the smaller daughter cell upon cytokinesis. In this cell, Numb inhibits Notch signaling while Pros represses the transcription of cell cycle genes and induces genes required for neuronal differentiation ([@bib16]). Brat can act as a translational repressor in other tissues ([@bib56]), and Brat-related proteins have been shown to regulate the transcription factor Myc and microRNAs ([@bib44; @bib53]). The exact molecular function of Brat in Nbs, however, is currently unclear.

In the absence of the cell-fate determinants *numb*, *pros*, or *brat*, the balance between self-renewal and differentiation is perturbed, resulting in the formation of a brain tumor ([@bib3; @bib8; @bib36]). In *brat* mutants, the small daughter cells of the type II Nbs fail to turn on INP markers and continue to express Nb characteristics ([@bib12]). The misspecified Nbs continue to divide asymmetrically, but no longer obey the signals that terminate Nb proliferation at the end of the larval period. When transplanted into adult host flies, they continue to proliferate indefinitely, become aneuploid, and start to metastasize ([@bib13]). Similar defects are observed upon inactivation of *numb* and *pros* in Nbs ([@bib3; @bib16; @bib12]), although in these cases, type I Nbs are affected as well. Tumors are also formed in mutants where the asymmetric localizations of Numb, Pros, and Brat are perturbed. Experiments using a mouse breast cancer model have indicated a similar causal relationship between asymmetric stem cell division and tumorigenesis ([@bib17]) in vertebrates. Consistently, human homologs of Numb ([@bib47]), Pros ([@bib48]), and Brat ([@bib11]) have all been connected to cancer, indicating that the results obtained in *Drosophila* are relevant for understanding mammalian tumorigenesis.

The genetic networks downstream of Brat, Numb, and Pros that restrict self-renewal to only one daughter cell are currently poorly understood. Microarray experiments ([@bib37]) and transcriptional target identification have identified lists of potential maintenance and differentiation regulators, but the functional relevance of these is largely unknown ([@bib16; @bib58]). In mammalian stem cells, genome-wide RNAi studies have been performed in cell culture ([@bib21; @bib32]). Ideally, however, stem cells should be studied in their natural environment where the interactions with the surrounding niche and the tissue-specific characteristics of individual lineages are maintained. In *Drosophila*, this has recently become possible through the establishment of a transgenic RNAi library that can be expressed in a tissue-specific manner ([@bib20]).

Here we use transgenic RNAi to analyze self-renewal in *Drosophila* Nbs on a genome-wide level. We identify 620 genes causing visible defects in Nb lineages and precisely quantify the resulting loss-of-function phenotypes. By integrating our functional data with publicly available gene- and protein-interaction data, we determine networks of functionally related genes that control cytokinesis, cell growth, and differentiation in the *Drosophila* brain. As our dataset is enriched for genes highly expressed in mammalian stem cells, it is likely to provide a valuable resource for mammalian stem cell biology as well.

Results and Discussion {#sec2}
======================

Screen Design {#sec2.1}
-------------

To analyze self-renewal in Nbs, we combined *insc*-Gal4 ([@bib8]) (expressed in type I and type II Nbs and INPs), with UAS-*CD8::GFP* (outlining cell membranes) to allow identification of most cells in each Nb lineage without the need for antibody staining. In a pilot screen, we could replicate the published loss-of-function phenotypes of *brat*, *pros*, and *numb* ([Figure 1](#fig1){ref-type="fig"}A). Since all lines causing visible phenotypes in the pilot screen are lethal when crossed to UAS-*Dicer-2*; *insc*-Gal4 (data not shown), we chose to screen for lethality first and analyze only the brains of lethal lines by confocal microscopy ([Figure 1](#fig1){ref-type="fig"}B). In total, we screened 17,362 RNAi lines from the VDRC GD library corresponding to 12,314 individual genes, approximately 89% of the annotated protein coding genes in *Drosophila*. 24.1% of the lines caused lethality (corresponding to 3412 or 27.7% of the analyzed genes) ([Figure 1](#fig1){ref-type="fig"}C, note that only genes that fit our quality criteria \[see below\] are represented in this panel). Among the 4182 lethal lines, analysis of CD8::GFP expression identified 832 lines (687 genes) that cause abnormalities in Nb, GMC, or INP number, size, or shape or cause the formation of intracellular CD8::GFP accumulations (note that only 620 of these fit our quality criteria and were included in the analysis; see below). We measured the average diameter and number of Nbs and their early daughter cells as well as the number and size of GFP aggregates within these cell types. From these measurements, we derived numbers that express phenotypic strength in 13 distinct categories on a scale from 0 to 10 (see [Experimental Procedures](#sec3){ref-type="sec"} for details). These quantitative phenotypic data are provided in [Table S1](#app3){ref-type="sec"} as well as an online database at <http://neuroblasts.imba.oeaw.ac.at>. Thus, our screen has identified and quantified putative loss-of-function Nb phenotypes for 4.5% of all protein coding genes in the *Drosophila* genome.

Quality Control {#sec2.2}
---------------

To evaluate the quality of our dataset, we made use of a second RNAi library (KK library) generated by site-specific integration of UAS-RNAi constructs. In this library, 314 lines were available for the 687 genes that caused visible brain phenotypes, and 235 of these (75%) are also lethal when crossed to *insc*-Gal4 (79 nonlethal lines). We randomly selected 135 lines from the lethal set for phenotypic analysis ([Figure 2](#fig2){ref-type="fig"}A; [Figure S1](#app3){ref-type="sec"}). We compared scores in the "GMC_less" category, the most frequent phenotype identified in the screen, and found that 121 KK lines display a phenotype identical to the corresponding GD line. For 14 lines (10.4%), only one of the two lines targeting the same gene had a phenotype in that category. To improve the overall reliability of the primary screening results, we used the S19 score that expresses the specificity of each RNAi construct on a scale from 0 (no specificity) to 1 (completely specific) ([@bib20]). Of 79 lethal GD lines where the corresponding KK line was viable, 25.3% had an S19 score of less than 0.85. However, only 6.4% of the 235 GD lines in which the lethality could be verified by a KK line were below this score. Thus, using the S19 score to predict quality of RNAi lines significantly improves specificity, and we therefore discarded lines with a score below or equal to 0.85 from our analysis. In 226 of the 288 lines that fit this criterion, lethality could be verified by a KK line, suggesting that the reproducibility of our final dataset is 78.5% ([Figure 2](#fig2){ref-type="fig"}B) and therefore higher than in previous transgenic RNAi screens ([@bib41]).

To test the expression pattern of the identified genes, we used expression data from Flyatlas ([@bib15]). The set of identified genes is significantly enriched for genes expressed in the larval CNS ([Figure 2](#fig2){ref-type="fig"}C). Surprisingly, the set is also enriched for genes expressed in ovaries, whereas most other tissues are underrepresented. This is probably because the expression of *insc*-Gal4 in other tissues like the gut or salivary glands causes early lethality for genes generally required in all tissues. Indeed, genes upregulated in a wide variety of tissues other than the larval brain are enriched among the "early lethal" genes for which lethality before the larval third instar prevented the analysis of brain phenotypes ([Figure 2](#fig2){ref-type="fig"}C and data not shown).

Close mammalian homologs were identified for 88.23% of the genes causing *Drosophila* phenotypes ([Table S1](#app3){ref-type="sec"}). To test the relevance of our dataset for mammalian stem cell biology, we compared the identified genes to previously assembled mammalian datasets that are based on expression and predicted function by searching the Molecular Signature Database (MSigDB) ([@bib59]). We found that our gene set is significantly enriched for genes highly expressed in mouse embryonic stem cells (ESCs) and neural stem cells ([Figure 2](#fig2){ref-type="fig"}D) ([@bib50]). Subsets of genes expressed in mammalian stem cells that cause phenotypes in *Drosophila* Nbs may represent valuable starting points for functional analyses and are provided in [Table S2](#app3){ref-type="sec"}.

Transcriptional Network for Self-Renewal {#sec2.3}
----------------------------------------

To isolate regulators of self-renewal among the genes identified in the screen, we used three strategies. First, we identified all putative transcription factors and chromatin regulators that cause either loss or underproliferation of Nbs and are candidate components of a transcriptional network for self-renewal. Second, we defined genes that cause Nb phenotypes and were previously shown to interact with known regulators of ACD, the key process controlling Nb self-renewal. Third, we used hierarchical clustering of our quantitative phenotypic data to identify groups of genes causing similar phenotypes.

Thirty-three experimentally verified or computationally predicted transcription factors and chromatin regulators cause underproliferation phenotypes ([@bib1; @bib49]). Among those are 13 known transcription factors, 12 genes whose domain composition implies a role in transcriptional regulation, and eight chromatin regulators ([Figure 2](#fig2){ref-type="fig"}E, see [Supplemental Information](#app3){ref-type="sec"} for explanation of network construction). These include the Polycomb group genes *Polycomb-like* (*Pcl*) and *multiple sex combs (mxc)*, but also *Su(z)12*, which has previously been implicated in Nb self-renewal ([@bib4]). In addition, we identified *Su(var)2-10*, the *Drosophila* homolog of *Pias1*; the *Hp1* homolog *Su(var)205*; the *Hdac1* homolog *Rpd3*; and *domino*, a gene that is also required for stem cell maintenance in *Drosophila* ovaries ([@bib61]). We also found the specific transcription factors *spalt related* (*salr*) ([@bib40]), *lethal of scute* (*l\[1\]sc*) ([@bib38]), *retinal homoebox* (*Rx*) ([@bib19]), and *longitudinals lacking* (*lola*) ([@bib27]), which have previously been implicated in nervous system development. Besides these known regulators, several putative transcription factors have not previously been characterized. *CG9895* is homologous to the mammalian Kruppel-like factors *Klf1*, *2*, *4*, and *8* ([@bib60]). *CG9571* has homology to mammalian *Foxg1* ([@bib18]), which is expressed in forebrain progenitors and involved in the regulation of self-renewal ([@bib54; @bib23]).

Regulatory Network for Asymmetric Cell Division {#sec2.4}
-----------------------------------------------

In Nbs, the ACD machinery ensures correct segregation of cell-fate determinants into the differentiating daughter cell. We used a set of 53 genes previously implicated in ACD or spindle orientation ([Figure 3](#fig3){ref-type="fig"}A) to query a database containing two-hybrid, biochemical, interolog, text-mining data, and genetic interactions between *Drosophila* genes (see [Experimental Procedures](#sec3){ref-type="sec"}). The resulting interaction network was reduced by only allowing connections with genes that had resulted in a phenotype in our screen ([Figure 3](#fig3){ref-type="fig"}A). To predict protein complexes and genetic pathways implicated in ACD we used clustering algorithms (MCODE, MCL, see [Experimental Procedures](#sec3){ref-type="sec"}). Three of the six protein complexes predicted in this way control cell cycle processes like kinetochore/mitotic spindle assembly, mitotic protein degradation (proteasome and anaphase promoting complex \[APC\]), and DNA replication. In addition, our analysis identified the RNA splicing machinery, the TRiC/CCT complex (TCP-1 ring complex or chaperonin containing T-complex 1), and a chromatin remodeling complex, which are discussed further below.

Alternative Splicing {#sec2.5}
--------------------

One of the complexes identified contains 35 genes that regulate various aspects of RNA metabolism and transcription ([Figure 3](#fig3){ref-type="fig"}A, "splicing"). Twenty-seven of these have previously been shown to regulate RNA splicing. Interestingly, eight of these genes were previously identified in an RNAi screen for alternative splicing ([@bib46]). In a cellular assay, B52, Hrb87F, CG6841, Pea, and U2af50 are needed for alternative splicing of *Dscam* while B52, Crn, and snRNP70K are involved in alternative splicing of *dAdar*, and CG10418 controls splicing of *paralytic*. In our screen, most of these genes caused underproliferation and loss of Nbs, and this might indicate a role for alternative splicing in Nb proliferation.

To identify potential targets of alternative splicing in Nbs, we searched for genes where individual RNAi lines resulted in divergent phenotypes. Interestingly, the gene *lola* is targeted by three different RNAi lines, one of which causes overproliferation in type II Nb lineages (GD12573) while the other two lines (GD41415, GD25333) cause underproliferation in both type I and type II lineages ([Figure 3](#fig3){ref-type="fig"}B; [Figure S2](#app3){ref-type="sec"}; online DB). This difference is not due to off-targets, as the overproliferation phenotype could be confirmed by another nonoverlapping RNAi line from the KK library (data not shown, see [Experimental Procedures](#sec3){ref-type="sec"} for details). Lola is a transcription factor involved in axon guidance during nervous system development ([@bib28]). The gene encodes at least 20 different isoforms that share a common N terminal BTB-domain, but differ in their C terminal Zn-finger region ([@bib28]). Both RNAi lines that cause overproliferation target the common N terminal region and are predicted to affect all of the 20 isoforms. The two lines causing Nb loss, however, specifically target the *lola* splicing isoforms B and N ([Figure 3](#fig3){ref-type="fig"}C). Thus, different splicing isoforms of *lola* seem to promote or inhibit Nb self-renewal.

To test whether *lola* isoforms are differentially expressed in Nbs versus neurons, we performed a microarray analysis of wild-type (WT) brains and *brat*-RNAi brains, which mostly consist of overproliferating type II Nbs. Interestingly, while isoforms D and H are downregulated in brat mutant brains, the expression of isoforms B, C, and S is significantly increased (see arrowheads in [Figure 3](#fig3){ref-type="fig"}C). Thus, alternative splicing of *lola* seems to be important for controlling proliferation in the developing *Drosophila* brain. Lola has been shown to not only antagonize the Notch pathway ([@bib63]), but also to enhance Delta-induced tumor formation ([@bib24]). Notch-Delta signaling is important for balancing proliferation and differentiation in *Drosophila* Nbs. Thus, the different phenotypes of the various *lola*-RNAi lines could be explained if different splicing isoforms would have distinct effects on Notch-Delta signaling.

TRiC/CCT Complex {#sec2.6}
----------------

The TRiC/CCT complex is the major ATP-dependent chaperonin in the eukaryotic cytoplasm ([@bib30]). It contains eight proteins that copurify with the protein phosphatase PP4 ([@bib26]). In our screen, four of these (*Cct5*, *Tcp-1eta*, *CG7033*, and *CG5525*) result in underproliferation phenotypes, while the others are early lethal (*Cct1γ*) or cause lethality without an obvious Nb phenotype (*Tcp-1like*, *CG8258*, and *Tcp-1ζ*). The catalytic subunit of PP4 itself (*Pp4-19C*) also causes Nb underproliferation, although a subset of Nbs displays an overproliferation phenotype ([Figures 3](#fig3){ref-type="fig"}A and 3D). The overproliferation phenotype is not confined to type II lineages, as it is also seen with *ase*-Gal4, which drives RNAi in type I lineages only ([Figure 3](#fig3){ref-type="fig"}D). In addition, one of the two regulatory subunits (*PPR2/PPp4R2r*) also results in Nb underproliferation.

In *Drosophila*, a previous study has identified PP4 as a regulator of the asymmetric localization of Mira and its cargo proteins Pros and Brat in dividing Nbs ([@bib57]). Whether PP4 acts in the TRiC/CCT complex to perform its role in Mira localization is currently unclear. PP4 has also been described to localize to centrosomes and act in centrosome maturation and spindle formation ([@bib31]), and this might provide an alternative explanation for the Nb phenotypes.

Hierarchical Clustering of Phenotypes {#sec2.7}
-------------------------------------

Our analysis has assigned to each gene a string of numbers describing a putative loss-of-function phenotype in Nbs. This "phenotypic barcode" allows us to computationally analyze and group genes based on the similarity of their Nb phenotypes. We used a hierarchical clustering algorithm on a reduced set of phenotypic categories describing Nb and GMC size, an increase or decrease in Nb number, and an increase or decrease in the number of daughter cells generated by each Nb. In addition, we included the presence of GFP-aggregates within a cell, a phenotype that might indicate cell death or any other disturbance of internal cellular membranes. The analysis identified several clusters of similar phenotype combinations and allowed for a clearly arranged visualization of our screening results ([Figure 4](#fig4){ref-type="fig"}A).

To define groups of genes that might perform a similar function, we used specific combinatorial criteria. Genes required for restricting self-renewal and potential tumor suppressors are expected to cause an increase in Nb or total cell number. We therefore generated an "overproliferation" group of 29 genes where "Nb_more ≥ 2" or "GMC_more ≥ 2." Analysis of genes promoting self-renewal is more complex. Such genes should cause a reduction of total cell number within Nb lineages. However, underproliferation is the most common phenotype in our analysis (538 of 620 genes) and can also arise from a number of unspecific biological defects, such as cell death or cell-cycle block. We therefore analyzed all genes where "Nb_less ≥ 2" and defined three mutually exclusive groups depending on whether Nb loss is associated with increased, decreased, or unchanged Nb size ([Figure 4](#fig4){ref-type="fig"}A). The Nb_loss_small, Nb_loss_large, and Nb_loss_normal groups were defined as "Nb_less ≥ 2 AND Nb_small ≥ 2," "Nb_less ≥ 2 AND Nb_large ≥ 2," and "Nb_less ≥ 2 AND Nb_small ≤ 1 AND Nb_large ≤ 1," respectively. Genes in the Nb_loss_large and the Nb_loss_normal groups are almost always associated with the accumulation of GFP aggregates, suggesting that they act in basic cellular processes ([Figure 4](#fig4){ref-type="fig"}A). Such aggregates are almost never observed in the Nb_loss_small group, indicating that those genes might play a role in cell growth, but are not essential for cell survival. In addition, the clustering algorithm identified a group of genes causing an extreme increase in Nb size without loss, and we combined those genes in the Nb_huge group ([Figure 4](#fig4){ref-type="fig"}A).

A GO term analysis showed that the various phenotypic groups are highly enriched for genes regulating specific cellular functions ([Figure 4](#fig4){ref-type="fig"}B; [Figure S3](#app3){ref-type="sec"}). This was further confirmed by analyzing the Nb_huge group in more detail. Interaction network analysis of this group identified a complex containing the known cytokinesis regulators *Incenp*, *zipper*, *aurora B*, and *Deterin* ([Figures S4](#app3){ref-type="sec"}A and S4B), as well as the tubulin subunits *betaTub60D* and *alphaTub67C* and the kinase *Pka-C2*. Indeed, actin staining of these RNAi lines reveals massive enlargement of Nbs and increased cellular DNA content characteristic of a cytokinesis defect ([Figure S4](#app3){ref-type="sec"}C).

Cell Growth and Nb Self-Renewal {#sec2.8}
-------------------------------

Genes required for Nb self-renewal should cause a loss of Nbs. Together with genes required for Nb survival, they should be in the groups Nb_loss_small, Nb_loss_large, and Nb_loss_normal. As Caspase staining revealed that the number of apoptotic cells was increased in the Nb_loss_normal and Nb_loss_large groups, but not in the Nb_loss_small group ([Figure 2](#fig2){ref-type="fig"}A, data not shown), we focused on the Nb_loss_small group for further analysis. Network analysis of this group identified a cluster of genes regulating ribosome biogenesis and protein biogenesis ([Figure 5](#fig5){ref-type="fig"}A). Surprisingly, however, most other ribosomal subunits cause early lethality (data not shown). Thus, most ribosomal subunits are required in all *Drosophila* cells, while some have a more specific function. Among those are RpL10Aa and RpS10a ([Figure 5](#fig5){ref-type="fig"}B), but also RpS5b, a subunit that causes an Nb underproliferation phenotype below the cutoff threshold. These subunits are duplicated in the *Drosophila* genome ([@bib39]) and, in all cases, the alternative isoform (RpL10Ab, RpS10b, and RpS5a, respectively) causes early lethality. A previous gene expression analysis has revealed that *RpS10a* and *RpS5b* are significantly overrepresented in *Drosophila* ovarian stem cells ([@bib33]). Our results indicate that certain ribosomal subunits are duplicated in the fly genome with one isoform being required in all cells and another isoform acting more specifically in stem cell lineages.

Functional diversification of duplicated ribosomal subunits has been demonstrated before in yeast. In *S. cerevisiae*, several ribosomal subunits exist as two isoforms that serve distinct functions and cause different phenotypes when deleted ([@bib34]). In vertebrates, duplication of ribosomal protein genes is rare, although multiple splice variants exist that can be expressed in a tissue-specific manner ([@bib42]). In humans (but not mice), the *Rps4* gene is duplicated. The two isoforms RPS4X and RPS4Y are located on the X and Y chromosomes, respectively ([@bib25]), and RPS4Y has been implicated in Turner syndrome ([@bib25]). Taken together, these data suggest that cell growth and ribosome biogenesis are rate-limiting for stem cell self-renewal in the *Drosophila* brain.

Differentiation and Tumor Suppression {#sec2.9}
-------------------------------------

Inhibitors of self-renewal and genes required for differentiation are expected to be in the overproliferation group. However, apparent overproliferation phenotypes could also be generated by longer GFP expression in Nb lineages or by an increase in proliferation. Since the CD8::GFP reporter did not allow us to distinguish those, we stained all 29 lines in the overproliferation group for the Nb marker Mira and for Pros, a marker for GMCs and neurons. This analysis identified 18 genes where RNAi results in the formation of extra Nbs ([Figure 6](#fig6){ref-type="fig"}; [Figure S5](#app3){ref-type="sec"}).

Interaction network analysis of the overproliferation genes revealed two protein complexes ([Figure 6](#fig6){ref-type="fig"}A). The first complex contains the segregating determinants Numb, Pros, Mira, and Brat and the phosphatase PP4 (see above, [@bib57]). Numb connects to α-Adaptin and AP-2σ, two components of the AP2 complex that has been shown to bind to Numb ([@bib7]). Knockdown of *α-Adaptin* or *AP-2σ* results in the formation of ectopic Nbs that coexpress Mira and Dpn, but are negative for the neuronal markers Pros and Elav ([Figure 6](#fig6){ref-type="fig"}B; [Figure S5](#app3){ref-type="sec"}A; data not shown). A similar overproliferation phenotype is evident in clones of *α-Adaptin* mutants, confirming the specificity of the RNAi line ([Figure S5](#app3){ref-type="sec"}D). To address where *α-Adaptin* and *AP-2σ* are required, we used *ase*-Gal4, which is specific to type I lineages, and *wor*-Gal4, *ase-*Gal80, which is specific to type II lineages ([Figure S5](#app3){ref-type="sec"}E, see [Supplemental Information](#app3){ref-type="sec"}). Using those lines, we found that the AP-2 complex is required in both type I and type II Nbs ([Figures S5](#app3){ref-type="sec"}B and S5C). Thus, Numb might exert its tumor suppressor function by regulating endocytic trafficking via the AP-2 complex.

Chromatin Remodeling {#sec2.10}
--------------------

The second complex contains the genes *brahma* (*brm*), *moira* (*mor*), and *osa*, which are part of the chromatin remodeling Brm complex ([@bib45]). RNAi of either *brm*, *mor*, or *osa* results in the generation of extra Mira-positive Nbs at the expense of Pros-positive neurons ([Figure 6](#fig6){ref-type="fig"}C). Expressing RNAi with *wor*-Gal4, *ase*-Gal80 resulted in an overproliferation phenotype, while *ase*-Gal4 had no effect, indicating that type II Nbs are more sensitive to the loss of the Brm complex ([Figures 6](#fig6){ref-type="fig"}D and 6E).

Components of the mammalian SWI/SNF complexes have been implicated in tumor suppression ([@bib51]) and in controlling the balance between proliferation and differentiation in mammalian neural stem cells ([@bib62]). Consistent with this, mammalian homologs of Brm and Osa are upregulated in mouse neural stem cells ([Figure 6](#fig6){ref-type="fig"}A).

Transcriptional Elongation {#sec2.11}
--------------------------

In the overproliferation network, the Brm complex connects to the genes *Ssrp* and *CG6049* ([Figure 6](#fig6){ref-type="fig"}A). RNAi targeting *Ssrp* or *CG6049* results in an expansion of Nbs at the expense of neurons ([Figure 6](#fig6){ref-type="fig"}B; [Figure 7](#fig7){ref-type="fig"}B). Ssrp is a subunit of the so-called FACT complex that is required for transcriptional elongation on chromatin templates ([@bib6]). The FACT complex acts by destabilizing nucleosomes and facilitates transcription by allowing PolII to pass. It is connected to the Brm complex because the yeast version of the Brm complex (Swi/Snf) is also implicated in histone disassembly and removal during transcriptional elongation ([@bib52]).

CG6049 is the *Drosophila* homolog of human Tat-SF1 ([@bib64]). Besides roles in HIV infection and RNA splicing, Tat-SF1 also has a prominent function in transcriptional elongation. It is an activator and binding partner of the Paf1 complex and the transcription elongation factor DSIF ([@bib14]). Together with the negative elongation factor NELF, DSIF can cause stalling of PolII transcription, while Paf1 and Tat-SF1 are cofactors for activating transcriptional elongation. As the FACT complex is one of the most prominent genetic and physical interaction partners of Paf1 ([@bib6]), all genes in the Brm/CG6049/Ssrp interaction network may regulate Nb self-renewal through a common mechanism.

*Barc* Regulates Intermediate Neural Progenitors {#sec2.12}
------------------------------------------------

As *CG6049* had not been characterized before, we chose this gene for in-depth analysis. We renamed *CG6049* into *barricade* (*barc*) to indicate the block in Nb lineage progression we observed upon RNAi. *Barc* is conserved from yeast to humans. Like its vertebrate homolog Tat-SF1, it contains two RNA recognition modules (RRM), a nuclear localization signal, and a conserved region that contains two motifs that are known to bind to FF domains ([@bib55]) and that we named the Barc-Tat-SF1 (BTS) motif ([Figure 7](#fig7){ref-type="fig"}A). To determine the specificity of the *barc*-RNAi phenotype, we generated an RNAi-resistant *barc* construct (see [Experimental Procedures](#sec3){ref-type="sec"} for details). When expressed together with *barc*-RNAi, this construct can rescue both lethality and the Nb phenotype ([Figures 7](#fig7){ref-type="fig"}B and 7E). In addition, the *barc*-RNAi phenotype could be confirmed by a second, nonoverlapping RNAi line ([Figure S6](#app3){ref-type="sec"}A). Thus, *barc* is a regulator of lineage progression in *Drosophila* Nbs.

While *barc*-RNAi in type II lineages using *wor*-Gal4; *ase*-Gal80 causes overproliferation ([Figure 7](#fig7){ref-type="fig"}C), *barc*-RNAi induced by ase-Gal4 has no overproliferation phenotype (data not shown). The additional CD8::GFP-positive cells in the type II lineages express Cyclin E, indicating active proliferation ([Figure 7](#fig7){ref-type="fig"}B), and do not express the neuronal marker Elav ([Figure 7](#fig7){ref-type="fig"}E). We observe more cells positive for Mira and Dpn ([Figures 7](#fig7){ref-type="fig"}B and 7C; [Figure S6](#app3){ref-type="sec"}B), which are expressed both in Nbs and in INPs. On average, the number of Mira-positive cells is approximately 4-fold increased ([Figure 7](#fig7){ref-type="fig"}D). As we only detect one large Ase-negative type II Nb, and the extra cells express the INP marker Ase ([Figure 7](#fig7){ref-type="fig"}F), we conclude that *barc* is required for INPs to generate differentiating neurons. Upon *barc*-RNAi, the daughter cells retain the INP fate, and this results in the overproliferation phenotype. Although *barc*-RNAi does not cause a similar overproliferation phenotype in type I lineages, we observe that the diameter of type I Nbs is increased from 15 ± 0.31 μm (SEM, n = 47) to 17.16 ± 0.27 μm (SEM, n = 43) ([Figure 7](#fig7){ref-type="fig"}G). This phenotype could either indicate an increase in growth rate or a decrease in cell cycle progression. Thus, *barc* is required for lineage progression in type II Nb lineages, but might also have a function in mitotic progression of type I Nbs.

To test Barc expression and subcellular localization, we generated a peptide antibody. The antibody detects a single band of approximately 75 kD on a western blot ([Figure S6](#app3){ref-type="sec"}C), which can be blocked by the antigenic peptide ([Figure S6](#app3){ref-type="sec"}C). The anti-Barc immunofluorescence signal is absent after *barc*-RNAi ([Figure S6](#app3){ref-type="sec"}D) and increases upon Barc overexpression (data not shown). Barc antibody staining revealed that Barc is a nuclear protein that is predominantly expressed in both type I and type II Nbs and to a lesser extent in INPs, GMCs, and differentiated neurons ([Figures S6](#app3){ref-type="sec"}D and S6E). Thus, we have identified a nuclear regulator of type II Nb lineages that allows INPs to generate daughter cells, which undergo terminal neural differentiation.

Conclusions {#sec2.13}
-----------

Our screen has identified a total of 620 genes that are potentially involved in controlling self-renewal in *Drosophila* neural stem cells. We demonstrate that precise quantification of phenotypic data allows for a computer analysis that can lead to biological insights that are not easily obtained through classic single-gene approaches. Through network analysis, we have identified splicing control as a key regulator of Nb self-renewal. Alternative splicing of *lola* might be one of the targets of this machinery as different isoforms of this transcription factor are differentially expressed and phenotypically distinct. We also show that duplicated forms of ribosomal subunits are functionally distinct, with one form being more specifically required in Nbs. Finally, we demonstrate that genes involved in transcriptional elongation and chromatin remodeling are important regulators of Nb self-renewal and differentiation. It is known that more than one third of all *Drosophila* genes are in a poised state where active RNA polymerase is stalled in a promoter proximal position. Release of stalled polymerases might contribute to the rapid activation of differentiation genes during Nb ACD. Transcriptional elongation is important for controlling vertebrate stem cell lineages as well ([@bib2]), but how stalled promoters are released in a cell-type-specific manner is currently unknown. Analysis in the simple *Drosophila* Nb lineage could shed some light on this important question in stem cell biology.

Experimental Procedures {#sec3}
=======================

Genome-Wide RNAi Screen {#sec3.1}
-----------------------

Males from the Vienna *Drosophila* RNAi Center (VDRC) carrying an inducible UAS-*RNAi* construct were crossed to virgins of the driver line containing UAS-*Dicer-2*; *insc*-Gal4, UAS-*CD8::GFP*. Crosses were set up at 25°C and transferred to 29°C after 1 day. In case of homozygous RNAi lines, crosses were flipped after 4 days. Lethality was determined in the first cross by the presence of balancer chromosome flies only. In case of lethality, larvae of the right genotype were identified by *insc*-Gal4-driven CD8::GFP (brain and salivary gland) using a fluorescence microscope. Six larvae per genotype were dissected in PBS and fixed in 5% PFA in PBS for 20 min. After mounting the specimen in Vectashield, a confocal stack of the brain was recorded using a ZEISS LSM confocal microscope. All phenotypic abnormalities were recorded and stored in a database (<http://neuroblasts.imba.oeaw.ac.at>).

Phenotypic annotations were performed with the LSM image examiner software. Phenotypes affecting the whole brain were described using numbers ranging from 0 to 10 depending on their strength (0 indicates WT, 1 indicates a possible phenotype that is below a cutoff, and numbers from 2 to 10 represent definitive phenotypes with increasing strength). Phenotypes that are only detectable in a defined region of the brain, whereas other parts are not affected, were quantified using a similar scoring system in a "regional" field, but back-calculated into a global average for computational analysis. These quantified "phenotypes" were then used to create different "categories" for the bioinformatic analysis (see text and [Supplemental Information](#app3){ref-type="sec"} for details).

Fly Strains and Clonal Analysis {#sec3.2}
-------------------------------

Besides the driver line, the following fly strains were used: *ase*-Gal4 ([@bib65]) and *wor*-Gal4, *ase*-Gal80 always in combination with UAS-*Dicer-2*; UAS-*barc*, UAS-*barc-resistant*, UAS-*barc-RNAi-2^nd^ line* (see [Supplemental Information](#app3){ref-type="sec"} for details on cloning and constructs), MARCM stocks using *elav-*Gal4 (*C155*) ([@bib35]), FRT40A, and *alpha-Adaptin^3^* ([@bib29]).

RNAi crosses were set up at 25°C and larvae were raised at 29°C. Brains of wandering third instar larvae were dissected and further processed for immunofluorescence. The KK line (KK101925) targeting *lola* was early lethal when crossed to *insc*-Gal4 and was therefore crossed to *wor*-Gal4, *ase*-Gal80 that has a more restricted expression area. For MARCM experiments, larvae were heat-shocked for 1 hr at 37°C and dissected 3 or 4 days later as wandering third instar larvae.

Antibodies {#sec3.3}
----------

Antibodies used in this study are rabbit anti-Mira (1:100, [@bib8]), mouse anti-Pros (1:10, Developmental Studies Hybridoma Bank, University of Iowa \[DSHB\]), guinea pig anti-Ase (1:100, [@bib9]), guinea pig anti-Dpn (1:1000, gift from J. Skeath), rabbit anti-Elav (1:300 \[DSHB\]), rat anti-Mira (1:100), rabbit anti-Caspase (1:200, Cell Signaling Technology), and mouse anti-PhosphoH3 (1:1000, Cell Signaling Technology). Barc-specific antisera were generated in rabbits against the C-terminal peptide: MKEEDVDSPENQLLPGDATP. Immunohistochemistry experiments were performed as previously described ([@bib8]).

Gene Expression and Bioinformatics Analyses {#sec3.4}
-------------------------------------------

Total RNA was isolated from third instar larval brains of either wild-type or *brat*-RNAi (GD31333 and KK105054) crossed to UAS-*Dicer-2*; *insc-*Gal4, UAS-*CD8::GFP*/CyO. The experiments were done in triplicates. For details on sample preparation, data processing---which was done at the Microarray DNA Facility of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden---and data analysis, see [Supplemental Information](#app3){ref-type="sec"}. The data is deposited at the ArrayExpress Archive (<http://www.ebi.ac.uk/arrayexpress/>) and has the ArrayExpress accession: E-MEXP-3112. Details on bioinformatics tools used for GO term, network, and cluster analyses are in [Supplemental Information](#app3){ref-type="sec"}.

Accession Numbers {#app1}
=================

The accession number for the new microarray data reported in this paper is E-MEXP-3112.

Supplemental Information {#app3}
========================

Document S1. Six figures and Supplemental Experimental ProceduresTable S1List of genes with their respective neuroblast RNAi phenotypes and mammalian orthologs (s19filtered \> 0.85).Table S2List of genes with their respective neuroblast RNAi phenotypes and mammalian orthologs (s19filtered \> 0.85) AND their expression in mammalian stem cells (MSigDBv2.5 data).
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Supplemental Information includes six figures, two tables, and Supplemental Experimental Procedures and can be found with this article online at [doi:10.1016/j.stem.2011.02.022](10.1016/j.stem.2011.02.022).

![Transgenic RNAi Screen\
(A) Larval brains expressing RNAi targeting *brat*, *numb*, or *pros* by *insc-*Gal4 (and control: no RNAi) stained for Miranda (Mira) CD8::GFP marks *insc-*Gal4 expression area. (Overview and close up.)\
(B) Workflow of the in vivo, genome-wide Nb RNAi screen.\
(C) Lethality rate of the primary genome-wide RNAi screen (GD library). Progeny of all lethal and semiviable crosses were dissected and brains were analyzed by confocal microscopy. (Note: Only lines with an S19 score \> 0.85 are considered in this analysis.)](gr1){#fig1}

![Quality Control and Transcriptional Regulators\
(A) Larval brains expressing nonoverlapping GD and KK RNAi lines targeting the same gene for different phenotypes and no RNAi (control): *Brat*-RNAi (GD31333 and KK105054) as an example for overproliferation stained for Dpn and Elav. For underproliferation, *Orc2*-RNAi (GD47604 and KK107035, Nb_loss_large) stained for Mira and Caspase, *nop56*-RNAi (GD51775 and KK103738, Nb_loss_small) stained for Mira and Pros, *dia*-RNAi (GD20518 and KK103914, Nb_huge) stained for Actin, and DNA are shown. (For a full list see also [Figure S1](#app3){ref-type="sec"}.)\
(B) Lethality rate of a rescreen using the KK RNAi library. Lines for the rescreen were chosen from GD lines of the primary RNAi screen that were lethal and resulted in a visible phenotype in Nb lineages.\
(C) Heat map showing over- and underrepresentation of tissue-specific gene sets (as defined by their transcriptional upregulation in the listed tissues) in the phenotypic categories found in the screen (L. represents larval tissue). Color code represents Z-score with colors from red (underrepresented) to blue (overrepresented) (see [Experimental Procedures](#sec3){ref-type="sec"} for details).\
(D) Table containing overlap of mammalian orthologs of genes that resulted in a phenotype in the primary RNAi screen with mammalian gene sets available from MSigDB v2.5. The data set is significantly enriched for genes that are upregulated in murine neural stem cells and embryonic stem cells compared to differentiated cells.\
(E) Network of transcriptional regulators that result in Nb maintenance defects upon knock down. Genes are shown as nodes, and node color reflects the phenotype (blue denotes underproliferation). The intensity of the color denotes the phenotypic strength. The node shape refers to the comparison of our data set with the gene set of the MSigDB v2.5 described in [Figure 2](#fig2){ref-type="fig"}D and [Table S2](#app3){ref-type="sec"} (circle: not annotated; rectangle: upregulated in mouse stem cells, including neural and/or hematopoietic and/or embryonic stem cells, compared to differentiated brain and bone marrow cells; triangle: only upregulated in mouse neural stem cells, but not in embryonic and hematopoietic stem cells). Edges denote the interaction/association of the nodes (edge width reflects evidence count: thick edges represent multiple evidences of interactions). Distinct molecular complexes are outlined in green. The remaining genes are sorted according to their known function and are highlighted in green.](gr2){#fig2}

![Regulatory Network for Asymmetric Cell Division\
(A) Network of genes implicated in ACD. Genes are shown as nodes and genes previously implicated in ACD are marked with a bold outline. The node color indicates the observed phenotype in the screen: blue for underproliferation, red for overproliferation that has been confirmed by a rescreen, and gray for GFP aggregates whereas the intensity of the color marks the phenotypic strength (note that genes causing both under- and overproliferation are shown in red). White nodes denote genes that did not score in our screen, but were implicated in ACD by other studies. The node shape refers to the MSigDB v2.5 data (see [Figure 2](#fig2){ref-type="fig"}E for details). Edges denote the interaction/association of the nodes (edge width reflects evidence count: thick edges represent multiple evidences of interactions). Distinct molecular complexes are outlined in green.\
(B) Larval brains expressing *lola*-RNAi (either against all isoforms \[all\] or one isoform \[B\]) or no RNAi (control) by *insc*-Gal4 and stained for Mira and Pros. (Overview and close up \[zoom 2\] and see also [Figure S2](#app3){ref-type="sec"}.)\
(C) Schematic showing Lola domain structure and *lola* isoforms. Blue squares represent a BTB (Bric-a-brac, Tramtrack, Broad-complex) domain and red squares represent a Zn finger domain. Each line represents a *lola* isoform. Green bars mark target regions of RNAi constructs. The colored isoforms are either differentially expressed in *brat*-RNAi versus WT (B, C, D, H, S, up- or downregulation additionally marked by an arrow) or were knocked down with an isoform-specific RNAi line (B and N).\
(D) Larval brains expressing *PpP4-19C*-RNAi or no RNAi (control) by *insc*-Gal4 (type I and type II Nb lineages) or *ase*-Gal4 (type I Nb lineages) and stained for Mira and Pros. (Underproliferation is marked by a white arrowhead and overproliferation is marked by a yellow arrowhead.) (Overview and close up \[zoom 2\].)](gr3){#fig3}

![Hierarchical Clustering of Phenotypes\
(A) Heat map representation of the established distinct phenotypes following agglomerative hierarchical clustering. Individual columns in the heat map represent scored phenotypes and the phenotypic profile of individual genes is displayed in rows. Colors denote the phenotypic score (white represents no phenotype, dark blue represents the strongest phenotype). Established groups are shown as boxes in the following colors: Nb_huge as orange; Overproliferation as red; Nb_loss_small, Nb_loss_large, and Nb_loss_normal as gray.\
(B) Heat map displaying over- and underrepresentation of selected GO terms in groups Nb_huge, Overproliferation, Nb_loss_small, Nb_loss_large and Nb_loss_normal (Color code represents Z-score with colors from red \[underrepresented\] to blue \[overrepresented\] \[see [Experimental Procedures](#sec3){ref-type="sec"} for details\].) (For additional analysis see [Figure S3](#app3){ref-type="sec"}.)](gr4){#fig4}

![Cell Growth and Nb Self-Renewal\
(A) Network for Nb_loss_small group. The intensity of the color marks the phenotypic strength. Node shape refers to MSigDB v2.5 data (see [Figure 2](#fig2){ref-type="fig"}E for details). Edges denote the interaction/association of the nodes (edge width reflects evidence count: thick edges represent multiple evidences of interactions). Distinct molecular complexes are outlined in green. (See also [Figure S4](#app3){ref-type="sec"}.)\
(B) Larval brains expressing *RpL10Aa*-RNAi, *RpS10a*-RNAi, or no RNAi (control) by *insc-*Gal4\>\>CD8::GFP and stained for Mira. Dotted lines outline individual Nbs. (Overview and close up \[zoom 2\].)](gr5){#fig5}

![Differentiation and Tumor Suppression\
(A) Network of genes resulting in overproliferation. The intensity of the color denotes the phenotypic strength. The node shape refers to the MSigDB v2.5 data (see [Figure 2](#fig2){ref-type="fig"}E for details). Edges denote the interaction/association of the nodes (edge width reflects evidence count: thick edges represent multiple evidences of interactions). Distinct molecular complexes are outlined in green. (See also [Figure S5](#app3){ref-type="sec"}.)\
(B) Larval brains expressing *daughterless*-RNAi, *AP2-sigma*-RNAi, *Ssrp*-RNAi, or no RNAi (control) by *insc-*Gal4 and stained for Mira and Pros (Overview and close up \[zoom 2\].)\
(C--E) Larval brains expressing RNAi targeting *brahma*, *moira*, and *osa* or no RNAi (control) by different Gal4-lines and stained for Mira and Pros. (C) *insc*-Gal4 (type I and type II Nb lineages). (D) *ase*-Gal4 (type I Nb lineages). (D) *wor*-Gal4, *ase*-Gal80 (type II Nb lineages). (Overview and close up \[zoom 2\].)](gr6){#fig6}

![*Barc* Regulates Intermediate Neural Progenitors\
(A) Schematic showing domain architecture and evolutionary conservation of Barc (CG6049): RNA recognition modules (RRM) in red, the conserved BTS motif in yellow, and NLS (highest confidence) in blue. Mm denotes *Mus musculus*; Dm, *Drosophila melanogaster*; Ce, *Caenorhabditis elegans*; Sc, *Saccharomyces cerevisiae*; At, *Arabidopsis thaliana*.\
(B) Larval brains expressing *barc*-RNAi or no RNAi (control) by *insc-*Gal4\>\>CD8::GFP and stained for Mira and CycE shown as merge and single channels (note the medio-posterior overproliferation in the middle panel). Rescue of overproliferation by coexpression of *barc*-RNAi with *barc*-RNAi resistant (right row). (See also [Figure S6](#app3){ref-type="sec"}.)\
(C) Larval brains expressing *barc*-RNAi or no RNAi (control) by *wor*-Gal4, *ase*-Gal80 (arrowheads mark type II lineages) and stained for Mira.\
(D) Quantification of Mira-positive cells in type II lineages per brain hemisphere (n denotes number of brain hemispheres analyzed; error bars represent standard error of the mean).\
(E) Larval brains expressing *barc*-RNAi or no RNAi (control) by *insc-*Gal4 and stained for Mira and Elav. Rescue of Elav expression by coexpression of *barc*-RNAi with *barc*-RNAi resistant (right row).\
(F) Close up of larval type II Nb lineages expressing *barc*-RNAi by *insc-*Gal4 and stained for Ase.\
(G) Quantification of Nb size in type I lineages (n denotes Nbs analyzed, error bars represent standard error of the mean).](gr7){#fig7}
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